Dengue cases in Malaysia fell 71% from 90,304 cases in 2020 to 26,365 cases in 2021, even as Khairy Jamaluddin highlights the worrying impact of climate change on dengue transmission.
Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalisations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in the ongoing pivotal Phase 3 TIDES trial.